These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2721521)

  • 1. A cytoplasmatic estrogen receptor related protein (ER-D5 Ag) in breast cancer.
    Nardelli GB; Marson S; Crocco M; Coronella ML
    Eur J Gynaecol Oncol; 1989; 10(2):141-3. PubMed ID: 2721521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ER-D5 antigen in breast cancer.
    Navarro MA; Guardia M; Arranz B; Bonnin MR; Rosel P
    J Cancer Res Clin Oncol; 1989; 115(3):290-1. PubMed ID: 2753930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ER-EIA and ER-D5-Ag-IRMA in breast cancer.
    Alessi A; Crocco M; Sandri A; Petrillo MR
    Eur J Gynaecol Oncol; 1989; 10(1):61-2. PubMed ID: 2645142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER-D5 antigen immune radiometric assay in breast cancer research.
    Nardelli GB
    Eur J Gynaecol Oncol; 1989; 10(1):9-12. PubMed ID: 2645143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical studies of the determination of the hormone receptor status of breast cancer].
    Brehler R; Bergholz M; Rauschecker H; Blossey HC; Schauer A
    Klin Wochenschr; 1986 Apr; 64(8):370-4. PubMed ID: 3517474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of cytoplasmic and nuclear estrogen receptors. A histochemical study on human mammary cancer and rabbit uterus.
    Lee SH
    Cancer; 1989 Oct; 64(7):1461-6. PubMed ID: 2550122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of histopathologic and immunohistochemical data (using the D5 antibody) and biochemical analysis in the study of estrogen receptors in breast carcinoma].
    Bussolati G; Pietribiasi F; Gugliotta P; Conti G; Di Carlo F
    Pathologica; 1987; 79(1059-1060):45-50. PubMed ID: 3441410
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
    Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
    Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer.
    Takeda H; Yamakawa M; Takahashi T; Imai Y; Ishikawa M
    Cancer; 1992 Feb; 69(4):907-12. PubMed ID: 1735082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of ER-D5 immunocytochemical determination in routine tissue sections of human breast cancer.
    Giani C; Campani D; De Negri F; Perpoli F; Capotorti E; Squartini F; Pinchera A
    Int J Biol Markers; 1989; 4(1):1-7. PubMed ID: 2545793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
    Iino Y
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay.
    Bilous AM; Tyler JP; Toppila M; Milliken J
    Pathology; 1987 Jul; 19(3):223-8. PubMed ID: 3324022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.